Phathom Pharmaceuticals Other Current Assets

Phathom Pharmaceuticals (PHAT) currently reports a other current assets of $8.3M as of June 2026. That compares with $15M in the prior-year period — down 43.2% year over year. Use the charts on this page to explore Phathom Pharmaceuticals's other current assets history and peer comparisons.

Phathom Pharmaceuticals's other current assets decreased from $15M to $8.3M — a 43.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Phathom Pharmaceuticals reported $8.3M in other current assets as of June 2026. That compares with $15M in the prior-year period — down 43.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $8.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phathom Pharmaceuticals, and consider following PHAT for alerts when major investors trade the stock.

Phathom Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $8.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHAT with unrelated industries.